| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.20T | 1.35T | 1.14T | 967.76B | 903.92B | 763.84B |
| Gross Profit | 87.14B | 94.63B | 79.80B | 78.21B | 70.52B | 64.14B |
| EBITDA | 34.04B | 46.19B | 38.08B | 17.23B | 31.77B | 28.68B |
| Net Income | 28.87B | 32.03B | 24.75B | 4.28B | 19.06B | 16.99B |
Balance Sheet | ||||||
| Total Assets | 420.31B | 462.07B | 440.12B | 405.26B | 406.69B | 356.20B |
| Cash, Cash Equivalents and Short-Term Investments | 19.12B | 45.15B | 55.42B | 69.37B | 52.12B | 46.96B |
| Total Debt | 20.70B | 18.37B | 21.53B | 21.87B | 27.22B | 28.73B |
| Total Liabilities | 265.69B | 292.24B | 287.81B | 263.12B | 262.72B | 220.03B |
| Stockholders Equity | 154.62B | 169.83B | 152.09B | 141.93B | 143.00B | 135.26B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 11.74B | 3.98B | 22.53B | 15.30B | 25.45B |
| Operating Cash Flow | 0.00 | 14.57B | 5.91B | 24.54B | 16.96B | 28.16B |
| Investing Cash Flow | 0.00 | -6.18B | -2.59B | -4.95B | -1.63B | -2.93B |
| Financing Cash Flow | 0.00 | -19.66B | -17.40B | -2.86B | -10.34B | -10.72B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥306.51B | 8.47 | ― | 3.08% | 18.83% | 33.06% | |
75 Outperform | ¥99.22B | 14.91 | ― | 2.72% | -3.00% | -13.90% | |
74 Outperform | ¥202.85B | 5.88 | 17.09% | 2.94% | 20.29% | 94.13% | |
72 Outperform | ¥55.32B | 14.67 | ― | 4.12% | 6.27% | 31.76% | |
64 Neutral | ¥40.20B | 8.77 | ― | 5.16% | 1.23% | -22.74% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
59 Neutral | ¥47.44B | 32.39 | 1.55% | 1.34% | -14.56% | 181.24% |